Expansion of CD4 T Lymphocytes Expressing Interleukin 17 and Tumor Necrosis Factor in Patients with Major Depressive Disorder
Open accessThe DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Abstract
Background: We have investigated the distribution of the Th1, Th2 and Th17 subsets in circulating CD4+ T lymphocytes and their naïve (TN), effector (TE), central (TCM) and effector memory (TEM) activation/differentiation stages in patients with major depressive disorder (MDD). Methods: Thirty MDD patients and 30 healthy controls were studied. The counts of circulating CD4+ T lymphocytes and their distribution on the TN, TE, TCM and TEM activation/differentiation stages were analyzed by polychromatic flow cytometry. The intracytoplasmic interferon gamma (IFNγ), interleukin (IL)-4, IL-17A and tumor necrosis factor alpha (TNF-alpha) and membrane CD28 expression were also measured. The serum IFNγ, IL-4, Il-17A and TNF-alpha were measured by Luminex, respectively. Results: MDD patients had normal counts of CD4+ T lymphocytes and of their TN, TCM and TEM subsets but increased number and percentage of TE CD4+ subset. CD4+ T lymphocytes had significantly enhanced percentage of cells that express IL-17 and TNF-alpha explained by the expansions found in the TN, TCM and, TEM and TCM, TEM and TE activation/differentiation stages, respectively. A selective increase in the percentages of TCM and TEM expressing IFNγ was also observed. We found a significant correlation between the percentages of CD4+ T lymphocytes expressing IFNγ and TNF-alpha in these patients. MDD patients showed increased serum levels of IL-17 and TNF-alpha, but normal IFNγ and IL-4 concentration. Limitations: the cross-sectional nature of the study could be considered a limitation. Conclusions: MDD patients have abnormal circulating CD4+ T lymphocytes with expansion of the IL-17 and TNF-alpha expressing cells as well as increased levels of circulating IL-17 and TNF-alpha.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The study data showed that the circulating Th17 cell count was higher with corresponding increased serum levels of IL-17-A.”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [147]
In the citing paper
“The IL-17A overexpression was observed in various activation/differentiation stages of CD4+ T cells, namely the naïve, central memory, and effector memory T cells [147].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
(1998) · PubMed · Cited by 10,216
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 1×
“Low-grade inflammation has been shown to influence neurotransmission, that is an important determinant in MDD pathogenesis and response to treatment [25].”
BackgroundCentral Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104702 · Cited by 3,067
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865 · cited 1×
“TN exhibit non-effector functions while TCM show high rates of proliferation and express multiple effector molecules, such as cytokines, in response to antigen stimulation and less intensive activation requirements [11,12].”
BackgroundRaison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443 · cited 1×
“Although contradictory results have been published, there is a general consensus indicating that MDD patients have abnormal circulating levels of pro-inflammatory and regulatory cytokines [15].”
Standardizing immunophenotyping for the Human Immunology Project
Maecker, H. T., McCoy, J. P., & Nussenblatt, R. (2012) · Nature Reviews Immunology · doi:10.1038/nri3158 · Cited by 1,176 · cited 2×
“Therefore, it has been proposed that CD4+ T lymphocyte subsets include CD45RA+CCR7+ naïve (TN), CD45RA-CCR7+ central memory (TCM), CD45RA-CCR7- effector memory (TEM) and CD45RA+CCR7- effector (TE) subsets [10].”
Background
Research works printed but not linked: 1
- 2. Malhi, G.S.; Mann, J.J. Depression. Lancet . Available online: https://linkinghub.elsevier.com/retrieve/pii/S0140673618319482 (accessed on 24 November 2018).
Cited by
Selected biomarkers of depression: what are the effects of cytokines and inflammation
Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010578 · Cited by 299
Kouba, B. R., de Araujo Borba, L., Borges de Souza, P., Gil-Mohapel, J., & Rodrigues, A. L. S. (2024) · Cells · doi:10.3390/cells13050423 · Cited by 209
“In line with this, a greater propensity for Th17 differentiation has been observed in individuals with MDD [157].”
BackgroundOrtega, M. A., Alvarez-Mon, M. A., García-Montero, C., Fraile-Martinez, O., Guijarro, L. G., Lahera, G., Monserrat, J., Valls, P., Mora, F., Rodríguez-Jiménez, R., et al. (2022) · Metabolites · doi:10.3390/metabo12010050 · Cited by 123
Self-citationThe Role of IL-17 Cytokines in Psoriasis
Mosca, M., Hong, J., Hadeler, E., Hakimi, M., Liao, W. J., & Bhutani, T. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s240891 · Cited by 127
Th17 cells and inflammation in neurological disorders: Possible mechanisms of action
Shi, Y., Wei, B., Li, L., Wang, B., & Sun, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932152 · Cited by 108
Zafiriou, E., Daponte, A., Siokas, V., Tsigalou, C., Dardiotis, E., & Bogdanos, D. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.699848 · Cited by 82
Ortega, M. A., Fraile‐Μartinez, O., Montero, C. G., Álvarez-Mon, M. Á., Lahera, G., Monserrat, J., Llavero-Valero, M., Gutiérrez-Rojas, L., Molina, R., Rodríguez–Jiménez, R., et al. (2022) · Nutrients · doi:10.3390/nu14153099 · Cited by 86
Self-citationMicroRNAs as critical biomarkers of major depressive disorder: a comprehensive perspective
Ortega, M. A., Alvarez-Mon, M. A., García-Montero, C., Fraile-Martinez, O., Lahera, G., Monserrat, J., Muñoz-Merida, L., Mora, F., Rodríguez-Jiménez, R., Fernandez-Rojo, S., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9111659 · Cited by 57
“Systemic inflammation with increased production of several cytokines and local neuroinflammation are central characters of MDD, opening a plethora of potential therapeutic windows [139,140].”
BackgroundSelf-citationOrtega, M. A., Fraile‐Μartinez, O., Montero, C. G., Haro, S., Álvarez-Mon, M. Á., León-Oliva, D. D., Gomez-Lahoz, A. M., Monserrat, J., Atienza-Pérez, M., Díaz, D., et al. (2023) · Military Medical Research · doi:10.1186/s40779-023-00461-z · Cited by 77
Self-citationMood and microbes: a comprehensive review of intestinal microbiota’s impact on depression
Luqman, A., He, M., Hassan, A., Ullah, M., Zhang, L., Khan, M. R., Din, A. U., Ullah, K., Wang, W. J., & Wang, G. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1295766 · Cited by 44
Álvarez-Mon, M. Á., Ortega, M. A., Montero, C. G., Fraile‐Μartinez, O., Monserrat, J., Lahera, G., Mora, F., Rodríguez-Quiroga, A., Fernández-Rojo, S., Quintero, J., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14080821 · Cited by 44
Self-citationÁlvarez-Mon, M. Á., Ortega, M. A., Montero, C. G., Fraile‐Μartinez, O., Lahera, G., Monserrat, J., Gomez-Lahoz, A. M., Molero, P., Gutiérrez-Rojas, L., Rodríguez–Jiménez, R., et al. (2022) · Journal of International Medical Research · doi:10.1177/03000605221094995 · Cited by 40
“Previous research from this research team demonstrated that patients with MDD exhibited an enhanced bacterial translocation, blunted regulatory T cell expansion, altered monocytes, an expanded CD4þ T cell population and dysregulated cytokines compared with non-depressed subjects.(38,39) Elevated plasma MDA levels shou…”
ResultSelf-citationT helper cells in depression: central role of Th17 cells
Ghosh, R., Mitra, P., Kumar, P. V. S. N. K., Goyal, T., & Sharma, P. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2021.1965535 · Cited by 38
Th17 Cells, Glucocorticoid Resistance, and Depression
Khantakova, J. N., Mutovina, A., Ayriyants, K. A., & Bondar, N. P. (2023) · Cells · doi:10.3390/cells12232749 · Cited by 38
“In the peripheral blood of depressed patients, the level of Th17 cells and IL-17a is significantly increased, the level of regulatory T cells is reduced, and the level of ROR γ T mRNA in peripheral blood lymphocytes is higher [92,94,95,97].”
BackgroundSoares, G. B., Mahmoud, O., Yosipovitch, G., & Mochizuki, H. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19813 · Cited by 40
“107 109 One study found that serum IL-17 levels were significantly higher in patients with rheumatoid arthritis compared to healthy controls, and that these levels positively correlated with severity of anxiety symptoms in these patients.”
BackgroundComorbidities in Psoriatic Arthritis: A Narrative Review
Panagiotopoulos, A. G., & Fragoulis, G. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.01.006 · Cited by 40
Min, Z., Li, Y., & Ying, H. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24559 · Cited by 33
T cell responses in depressed mice induced by chronic unpredictable mild stress
Shi, W., Zhang, S., Lu, Y., Wang, Y., Zhao, J., & Li, L. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.064 · Cited by 33
Depression Pathophysiology: Astrocyte Mitochondrial Melatonergic Pathway as Crucial Hub
Anderson, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010350 · Cited by 33
“Alterations in the levels, phenotypes and function of an array of diverse immune cells have been associated with MDD pathophysiology, including monocytes/macrophages [67], dendritic cells [68], t-helper (Th)17 cells [69], enteric glial cells [70], CD8+ t cells [71] and natural killer (NK) cells [72], usually in associ…”
BackgroundFenugreek and Its Effects on Muscle Performance: A Systematic Review
Albaker, W. I. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030427 · Cited by 29
Fraile‐Μartinez, O., Álvarez-Mon, M. Á., Montero, C. G., Pekarek, L., Guijarro, L. G., Lahera, G., Sáez, M. A., Monserrat, J., Motogo, D., Quintero, J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.956923 · Cited by 34
Self-citationTeixeira, A. L., Martins, L. B., Berk, M., & Bauer, M. E. (2022) · Clinical Science · doi:10.1042/cs20211106 · Cited by 22
Ortega, M. A., Fraile‐Μartinez, O., Montero, C. G., Díaz, R., López-González, L., Monserrat, J., Barrena-Blázquez, S., Álvarez-Mon, M. Á., Lahera, G., & Álvarez‐Mon, M. (2024) · Military Medical Research · doi:10.1186/s40779-024-00577-w · Cited by 39
“Similarly, CD4 T cells appear to be polarized toward a Treg and effector T phenotype, especially with a Th17 polarization [59, 60].”
Self-citationTh17-cells in depression: Implication in multiple sclerosis
Melnikov, M., & Lopatina, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010304 · Cited by 21
“They also found that the percentage of the total IL-17 producing CD4 T-cells among PBMCs was also higher in MDD patients (44).”
BackgroundShi, Y., Yang, H., He, C., Wang, Y., Zheng, J., Wang, X., Hao, F., Feng, C., Ma, L., Zhang, Y., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1614297 · Cited by 19
Ye, X., Ho, J. Y. S., & Chang, R. C. (2025) · Biomolecules · doi:10.3390/biom15111556 · Cited by 16
“Moreover, the expression levels of IL-17, IL-18, IL-21, IL-23, and IL-35 were substantially elevated in patients with depression [20–22].”
Wang, Q., Zhong, Y., Chen, N., & Chen, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1078984 · Cited by 12
Role of interleukin 17 (IL-17) in the inflammatory hypothesis of depression
Bliźniewska-Kowalska, K. M., Halaris, A. E., Gałecki, P., & Gałecka, M. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100610 · Cited by 15
Tie, S., Pan, Y., Pang, C., Saman, A., Dong, Y., Fang, S., Zhu, J., Wu, Y., & Gu, S. (2025) · Nutrients · doi:10.3390/nu17193087 · Cited by 11
“…through the following mechanisms, such as activating cells to secrete pro-inflammatory cytokines such as IL-6 and TNF-α , and destroying the blood–brain barrier and other pathways to affect the function of neurons and astrocytes, thus participating in the process of mental disorders [42,43].”
Ortega, M. A., Pekarek, T., Fraile‐Μartinez, O., Montero, C. G., Pekarek, L., Rodriguez-Martín, S., Moñux, R. M. F., Bravo, C., León-Luis, J. A. D., Lahera, G., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020656 · Cited by 11
Self-citationSchiweck, C., Aichholzer, M., Reif, A., & Thanarajah, S. E. (2022) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2022.100454 · Cited by 13
Li, S., Lv, D., Qian, C., Jiang, J., Zhang, P., Xi, C., Wu, L., Gao, X., Fu, Y., Zhang, D., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14361 · Cited by 13
Xue, H., Chen, J., & Fan, W. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.04.006 · Cited by 10
Tang, J., Zhao, S., Su, Y., Shi, H., Li, X., Zhang, X., Wang, J., Jin, X., & He, Y. (2025) · Experimental Dermatology · doi:10.1111/exd.70128 · Cited by 7
Ruyong formula improves thymus function of CUMS-stimulated breast cancer mice
He, B., Guo, W., Shi, R.-Z., Hoffman, R. D., Luo, Q., Yuanjia, H., & Gao, J. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117164 · Cited by 7
Fan, W., Zhu, D., Cao, L., Wang, S., Tong, Y., Xie, F., Zhang, X., Su, P., & Wang, G. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.07.027 · Cited by 7
He, J., Ren, Z., Xia, W., Zhou, C., Bi, B., Yu, W., & Zuo, L. (2021) · PeerJ · doi:10.7717/peerj.11694 · Cited by 5
Zhang, C., Ma, M.-H., Li, K., Xu, S., & Liu, Y. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00976-3 · Cited by 4
Fu, T., Zhang, W., Zhang, S., & Tian, F. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104927 · Cited by 4
Ryan, K. M., O’Rourke, A. M., Sheridan, C., Quintana, M. G., Moran, B., Fletcher, J. M., McLoughlin, D. M., & Harkin, A. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1693999 · Cited by 2
Iyer, S., Cao, Y., Liebegott, R., Chen, J., Ragab, A. A. Y., Doyle, M. F., Lunetta, K. L., & Murabito, J. M. (2025) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2025.107716 · Cited by 2
Haro, S., Gomez-Lahoz, A. M., Monserrat, J., Atienza-Pérez, M., Fraile‐Μartinez, O., Ortega, M. A., Montero, C. G., Díaz, D., López‐Dolado, E., & Álvarez‐Mon, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417596 · Cited by 3
Self-citation(2021) · PeerJ · doi:10.7287/peerj.11694v0.1/reviews/3
“The serum level of TNFα was increased in MDD patients, which was associated with depressive symptoms (Alvarez-Mon et al. 2021).”
Innate lymphoid cells in depression: Current status and perspectives
Madeshiya, A. K., & Pillai, A. (2022) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2022.100055
“MDD subjects showed abnormal circulating CD4+ T lymphocytes with expansion of the IL-17 and TNF-alpha expressing cells as well as increased levels of peripheral IL-17 and TNF-alpha (Alvarez-Mon et al., 2021).”
BackgroundImmunotherapy: A potential treatment strategy for depression
Zhang, C. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20230705cz · Cited by 4
Neuroinflammation and depression: An update
Huarcaya, L. R. D., & Ríos, M. F. D. (2023) · Journal of Phytomolecules and Pharmacology · doi:10.56717/jpp.2023.v02i01.016
“Researchers [9,10] found that the circulating population of CD4+ T cells had a stronger potential to evolve into Th17 in adult patients with MDD.”
BackgroundAffective Disorders: The Role of Adipokines
Dmitrzak‐Węglarz, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_94-1 · Cited by 1
Affective Disorders: The Role of Adipokines
Dmitrzak‐Węglarz, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_94
Molenda, K., Kuduk, A., Muszynski, S., Horecka-Lewitowicz, A., Piwonski, L., & Gorczyca-Glowacka, I. (2025) · Journal of Sexual and Mental Health · doi:10.5603/jsmh.106887
Δαπόντε, Α.-Ι. Α., & Δαπόντε, Α.-Ι. Α. (2025) · University of Thessaly Institutional Repository (University of Thessaly)
Favina, A., Fatch, R., Rao, S. R., Chamie, G., Muyindike, W. R., Adong, J., Emenyonu, N. I., Tumwegamire, A., Ngabirano, C., Kekibiina, A., et al. (2026) · AIDS and Behavior · doi:10.1007/s10461-026-05214-2
Liu, C., Li, Y., Cao, X., Ye, Z., Shi, Q., Chen, F., Li, Z., Guo, J., & Qiu, T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177532
“Some studies have reported reduced CD4+ T-cell levels in patients with MDD, whereas others have observed increased circulating CD4+ T cells expressing interleukin-17 and TNF [21].”
Zhang, S., Zeng, Z.-L., Lin, X.-E., Ran, J., Wang, Q., Yang, J.-B., Wu, Y., & Lin, N.-X. (2026) · Current Medical Science · doi:10.1007/s11596-026-00226-4
Ndhlovu, G., & de Voux, A. (2026) · medRxiv · doi:10.64898/2026.10.05.26364733
Poletti, S., Bravi, B., Calesella, F., Aggio, V., Vai, B., Finardi, A., Mandelli, A., Lorenzi, C., Colombo, C., Furlan, R., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122658
Metadata
- Authors
- Alvarez-Mon, M. A., Gómez-Lahoz, A. M., Orozco, A., Lahera, G., Diaz, D., Ortega, M. A., Albillos, A., Quintero, J., Aubá, E., Monserrat, J., & Alvarez-Mon, M.
- Affiliations
- Department of Psychiatry and Medical Psychology, University Clinic of Navarra, Avda. Pío XII, 36, 31008 Pamplona, Spain
- Department of Medicine and Medical Specialities, University of Alcala, 28871 Alcala de Henares, Spain
- Hospital Universitario Príncipe de Asturias (ES)
- Universidad de Alcalá (ES)
- Universidad Complutense de Madrid (ES)
- Clinica Universidad de Navarra (ES)
- Venue
- Journal of Personalized Medicine
- Publisher
- MDPI AG
- Published
- 2021-03-19
- Volume
- 11
- Issue
- 3
- Pages
- 220
- ISSN
- 2075-4426 (ISSN-L)
- PMC
- PMC8003656
- OpenAlex
- W3136411448
- Cited by
- 57
- References
- 44
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 7 · 2023: 12 · 2022: 12 · 2021: 14
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Personalized Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- e_Buah (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Instituto de Salud Carlos III (PI18/01726))
- Comunidad de Madrid (B2017/BMD-3804)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- major depressive disorder, CD4+ T cells, Th17 cells, IL-17, TNF-α, interferon-gamma, Th1/Th2 balance, central memory T cells, effector memory T cells, naive T cells, effector T cells, CD28, cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.